Rankin Aubrey

CIK 00018185761 companyNEWARK, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001818576

Recent Transactions

22 trades

Tax Payment
Revance Therapeutics, Inc.
Common Stock
2022-03-15$15.79/sh−1,372→ 94,091 total
Purchase
Revance Therapeutics, Inc.
Common Stock
2021-12-03$14.43/sh+30,000→ 95,463 total
Sale
Revance Therapeutics, Inc.
Common Stock
2021-08-16$26.34/sh−9,364→ 65,463 total
Tax Payment
Revance Therapeutics, Inc.
Common Stock
2021-08-15$26.02/sh−4,949→ 74,827 total
Sale
Revance Therapeutics, Inc.
Common Stock
2021-07-28$30.15/sh−20,000→ 154,302 total
Sale
Revance Therapeutics, Inc.
Common Stock
2021-07-28$30.00/sh−34,332→ 321,611 total
Sale
Revance Therapeutics, Inc.
Common Stock
2021-07-26$29.72/sh−55,382→ 355,943 total
Sale
Revance Therapeutics, Inc.
Common Stock
2021-04-05$28.28/sh−2→ 411,325 total
Sale
Revance Therapeutics, Inc.
Common Stock
2021-03-04$25.43/sh−33,119→ 411,327 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2021-02-02+21,540→ 21,540 total
Award
Revance Therapeutics, Inc.
Common Stock
2021-02-02+11,905→ 79,776 total
Sale
Revance Therapeutics, Inc.
Common Stock
2021-02-01$25.95/sh−33,119→ 444,446 total
Sale
Revance Therapeutics, Inc.
Common Stock
2020-12-30$27.82/sh−33,119→ 477,565 total
Sale
Revance Therapeutics, Inc.
Common Stock
2020-11-30$23.85/sh−33,119→ 510,684 total
Sale
Revance Therapeutics, Inc.
Common Stock
2020-10-29$26.15/sh−33,119→ 543,803 total
Sale
Revance Therapeutics, Inc.
Common Stock
2020-09-28$26.18/sh−33,119→ 576,922 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-07-23+57,251→ 667,292 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2020-07-23$2.54/sh+8,867→ 8,867 total
Award
Revance Therapeutics, Inc.
Employee Stock Option (Right to Buy)
2020-07-23$2.54/sh+44,828→ 44,828 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-07-23+57,251→ 67,871 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-07-23+610,041→ 610,041 total
Award
Revance Therapeutics, Inc.
Common Stock
2020-07-23+610,041→ 610,041 total

Companies

Revance Therapeutics, Inc.
Director, President, Innovation & Tech

Recent Filings

Address

C/O REVANCE THERAPEUTICS, INC 7555 GATEWAY BLVD

NEWARK, CA, 94560

View on SEC.gov